Wall Street snapped a two-week losing streak as headlines about President Donald Trump's remarks on tariff policy, economic data on inflation and corporate earnings took center stage. The S&P ...

Blackstone (NYSE:BX) and Corsair Capital are looking to sell First Eagle Investment Management for more than $4B, the Financial Times reported late Friday, citing people briefed on the matter.

Novartis has claimed accelerated approval ... while zigakibart is in phase 3. In 2021, Calliditas Therapeutics' corticosteroid-based Tarpeyo (budesonide) became the first FDA-approved therapy ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.